Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Beleave Inc BLEVF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Beleave Inc is a vertically integrated Canadian cannabis company. It operates streamlined facilities throughout Canada to cultivate high quality cannabis flower, oil and extracts with funded capacity more than 150,000 kilograms per year. Fully licensed to cultivate and sell medical and recreational cannabis, it is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. The company is currently developing new product lines as the recreational market is expected to allow for food and beverage-based cannabis products.


GREY:BLEVF - Post by User

Beleave Inc > January - Form 7 Progress Report
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(112)
•••
Comment by Wallhallaon Feb 11, 2020 6:49am
110 Views
Post# 30672366

RE:RE:RE:January - Form 7 Progress Report

RE:RE:RE:January - Form 7 Progress Report He is saying is the value of the stock will come down to the numbers.  It was the Company who said the margins for new products was "significant" and that packaging and shipping costs would be down 60 - 70% so its not unreasoanble to expect the numbers to be better this quarter. 



Eastcoaster16 wrote: So, please tell me how they are able to sell more product in their small facility? U keep pointing to quarterly numbers, what is your expectation?


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities